Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer-Reference-Cited by-同舟云学术

Factors associated with response to neoadjuvant chemotherapy in advanced stage ovarian cancer

Published:2021-07 Issue:1 Volume:162 Page:65-71
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Fleming Nicole D.,Westin Shannon N.,Rauh-Hain J. Alejandro,Soliman Pamela T.,Fellman Bryan M.,Coleman Robert L.,Meyer Larissa A.,Shafer Aaron,Cobb Lauren P.,Jazaeri Amir,Lu Karen H.,Sood Anil K.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Use and effectiveness of neoadjuvant chemotherapy for treatment of ovarian cancer;Meyer;J. Clin. Oncol.,2016

2. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States;Melamed;Gynecol. Oncol.,2016

3. Effect of adoption of neoadjuvant chemotherapy for advanced ovarian cancer on all cause mortality: quasi-experimental study;Melamed;BMJ,2018

4. Trends in surgical complexity and treatment modalities utilized in the management of ovarian cancer in an era of neoadjuvant chemotherapy;Homer;Gynecol. Oncol.,2019

5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N. Engl. J. Med.,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Clinical Research of NACT-IDS in Advanced Epithelial Ovarian Cancer;Advances in Clinical Medicine;2023

2. Clinical Characteristics and 8-year Survival Rate in Advanced Ovarian Cancer Following Neoadjuvant Chemotherapy: A Single Center Experience;Iranian Red Crescent Medical Journal;2022-10-06

3. Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review;Current Oncology Reports;2022-08-15

4. Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer;Journal of Gynecologic Oncology;2022